Opendata, web and dolomites

NUTRI-NEED SIGNED

Final development, clinical validation and launch preparation of NL01, an innovative health ingredient for supplements, food products and foods for special medical purposes

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NUTRI-NEED project word cloud

Explore the words cloud of the NUTRI-NEED project. It provides you a very rough idea of what is the project "NUTRI-NEED" about.

proprietary    track    clinical    isolated    obtain    projected    nl01    elderly    foods    medical    medium    status    company    dsm    abbott    kg    functional    leaders    250    registration    115    advice    eacute    perform    ec    revenues    desired    healthy    approved    game    small    life    immune    young    risk    supporting    friesland    regulatory    changer    consumers    ingredient    first    launch    components    works    companies    live    market    representing    nestl    campina    ingredients    function    benefits    food    claim    proven    danone    clinically    adults    efsa    inclusion    dietary    claims    containing    resistance    demand    entry    humans    supports    grant    data    deals    commercial    infections    infection    licence    industry    supplements    million    plant    46x    purposes    licensing    isolation    patients    gt    health    generate    huge    complete    cumulative    2026    preclinical    register    industrial    crop    nutrileads    people    fresenius    safety    population    shown    dynamic   

Project "NUTRI-NEED" data sheet

The following table provides information about the project.

Coordinator
NUTRILEADS BV 

Organization address
address: BRONLAND 12 N
city: WAGENINGEN
postcode: 6708 WH
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website https://nutrileads.com/investors/
 Total cost 3˙567˙000 €
 EC max contribution 2˙496˙900 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NUTRILEADS BV NL (WAGENINGEN) coordinator 2˙496˙900.00

Map

 Project objective

People want to live a long and healthy life and there is a huge demand for food products to enable this. Among consumers, the most desired health benefits in food products and supplements are ‘supports immune function’ and ‘increases resistance to infections’.

NutriLeads is a dynamic Health Ingredients company developing crop-derived food ingredients with clinically proven health benefits. With its proprietary lead ingredient NL01, having completed preclinical data and proven safety in humans, NutriLeads is on track to become the first company to launch an ingredient with an approved health claim for supporting immune function and increasing infection resistance. Targeted end-users of NL01 containing food products (dietary supplements, medical- and functional foods) are young adults, adults, elderly and patients, aiming to support their health and immune status.

Nutrileads selected a common crop from which NL01 can be isolated, a game-changer for its commercial success,and developed the isolation process for NL01 up to small scale industrial plant production. In this project, Nutrileads will perform medium scale-up of the production process to 250 kg. Nutrileads will complete the data package for NL01 with a clinical study in a relevant population with increased infection risk to support the health claims on NL01, register NL01 as ‘Novel Food’ and obtain European Food Safety Authority (EFSA) regulatory advice on registration as ‘Food for Specific Medical Purposes’.

NutriLeads will generate revenues from out-licensing NL01 to large companies in the food industry. Market leaders Abbott, Nestlé, Friesland Campina, Danone, Fresenius regularly in-licence components for inclusion in their products; Nestlé and DSM have already shown interest in Nutrileads’ products. Nutrileads works towards market entry and first deals during or directly after this project with a projected best-case cumulative revenues of €115 million in 2026, representing >46x the EC grant.

 Deliverables

List of deliverables.
NL01 brand & logo Websites, patent fillings, videos etc. 2019-08-01 13:00:52

Take a look to the deliverables list in detail:  detailed list of NUTRI-NEED deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NUTRI-NEED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NUTRI-NEED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

AMBRPAY (2019)

Decentralized subscription payments with cryptocurrency

Read More  

EVERCAM (2020)

Intelligent Vision System for Improved Communication and Higher Productivity in Construction

Read More